SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Andrew C. McCreary, Mark A. Varney, Adrian Newman-Tancredi, The Novel 5-HT1A Receptor Agonist, NLX-112 Reduces L-DOPA-induced Abnormal Involuntary Movements in Rat: a Chronic Administration Study with Microdialysis Measurements, Neuropharmacology, 2016,

    CrossRef

  2. 2
    H. Iderberg, A.C. McCreary, M.A. Varney, M.S. Kleven, W. Koek, L. Bardin, R. Depoortère, M.A. Cenci, A. Newman-Tancredi, NLX-112, a novel 5-HT1A receptor agonist for the treatment of l-DOPA-induced dyskinesia: Behavioral and neurochemical profile in rat, Experimental Neurology, 2015, 271, 335

    CrossRef

  3. 3
    Erwan Bezard, Experimental reappraisal of continuous dopaminergic stimulation against L-dopa-induced dyskinesia, Movement Disorders, 2013, 28, 8